InMed Pharmaceuticals (INM) Debt Ratio (2021 - 2022)
InMed Pharmaceuticals (INM) reported Debt Ratio of 0.0 for Q1 2022, down 37.41% quarter-over-quarter from 0.0 in Q4 2021.
InMed Pharmaceuticals (INM) Debt Ratio (2021 - 2022) Analysis & Trends
InMed Pharmaceuticals has reported Debt Ratio for 2 years, with the latest figure at 0.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.42 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.60 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.30 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.35 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.24 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | InMed Pharmaceuticals | 6.00 Mn | 756,271.05 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |